middle.news
How Is Chimeric Therapeutics Advancing CAR-T Trials with FDA Fast Track and $6.6M Raise?
12:02pm on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
How Is Chimeric Therapeutics Advancing CAR-T Trials with FDA Fast Track and $6.6M Raise?
12:02pm on Tuesday 29th of July, 2025 AEST
Key Points
Dose escalation to level 2 in CHM CDH17 Phase 1/2 trial
FDA grants Fast Track Designation for GEP-NET treatment
Fourth US clinical site activated at Emory Winship Cancer Institute
Early encouraging results from ADVENT-AML Phase 1B trial
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CHM
OPEN ARTICLE